Filter by:
This year, 132 specialised drug treatment centres (CSAPA) participated in the RECAP survey (common data collection on addictions and treatments), out of a total of around 500 CSAPAs, providing data on more than 210 000 patients.
Since 1999, the monitoring carried out by the Emerging Trends and New Drugs (TREND) scheme of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has made it possible to describe the population groups that are particularly dependent on psychoactive substances and to identify emerging phenomena in the field of illicit drugs and diverted medicines.
For ten years the OFDT has been publishing an updated report on drugs and drug addictions in France based upon data scientifically validated.
In April 1999, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) carried out a survey based on the opinions and perceptions relating to drugs and drug addiction.
As a minority in specialised care services, French women presenting with addictions represent 23% and 18% of the public seen in specialised drug treatment centres (CSAPA) and harm reduction facilities (CAARUD) respectively.
Since 1995, the French monitoring center for drugs and drug addiction (OFDT), has been assigned the task of publishing a regular report on the state of the phenomenon of drugs and dependence.
Since the French "delinquency prevention act" of 5 March 2007, which mainly aimed to "increase the efficacy of the legal system's handling of drug addiction", people arrested for narcotics possession and use can now be ordered by the courts to undergo an "awareness course on the dangers of drug and alcohol use".
The study on the use of analgesic opioid medicines (EMOA) by the French Monitoring Centre for Drugs and Drug Addiction (OFDT) examines their prescription in general practice and the experiences of who consider themselves to be having difficulty with them in the treatment of chronic pain unrelated to cancer in France.
The French Monitoring Centre for Drugs and Drug Addiction (OFDT) publishes the first results of the Study on the use of analgesic opioid medicines (entitled EMOA).
The illegal production of synthetic drugs (e.g. amphetamines, MDMA/ecstasy, methamphetamine) poses significant environmental risks, including soil and water contamination.